PCM
TMO icon

Permanent Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Permanent Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245K Buy
511
+29
+6% +$15.7K 0.04% 137
2025
Q4 		$280K Sell
482
-162
-25% -$91.6K 0.05% 113
2025
Q3 		$313K Buy
+644
New +$300K 0.06% 109
2025
Q1 		$363K Buy
729
+3
+0.4% +$1.63K 0.1% 44
2024
Q4 		$378K Buy
+726
New +$399K 0.12% 40
2024
Q2 		$261K Buy
+644
New +$369K 0.05% 119

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Permanent Capital Management's TMO Position: Q1 2026 in Review

Permanent Capital Management increased its Thermo Fisher Scientific (TMO) stake by 6% in Q1 2026, buying an estimated $15.7K and bringing the position to 511 shares worth $245K. The position accounts for 0.04% of the portfolio, ranked #137.

Permanent Capital Management first reported a position in TMO in Q2 2024 and has held it in 6 quarters since. The position peaked at $378K in Q4 2024. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Permanent Capital Management held 511 shares of Thermo Fisher Scientific worth $245K as of Q1 2026.
  • Permanent Capital Management bought 29 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.7K.
  • Thermo Fisher Scientific made up 0.04% of Permanent Capital Management's portfolio in Q1 2026, its #137 holding.
  • Permanent Capital Management first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 6 quarters since.
  • Permanent Capital Management's Thermo Fisher Scientific position peaked at $378K in Q4 2024.
  • 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Permanent Capital Management's 13F filing for Q1 2026, filed 14 May 2026.